These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 21107661)

  • 21. A whole-body physiologically based pharmacokinetic model incorporating dispersion concepts: short and long time characteristics.
    Oliver RE; Jones AF; Rowland M
    J Pharmacokinet Pharmacodyn; 2001 Feb; 28(1):27-55. PubMed ID: 11253612
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Using the time of maximum effect site concentration to combine pharmacokinetics and pharmacodynamics.
    Minto CF; Schnider TW; Gregg KM; Henthorn TK; Shafer SL
    Anesthesiology; 2003 Aug; 99(2):324-33. PubMed ID: 12883405
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Basic concepts of pharmacokinetic/pharmacodynamic (PK/PD) modelling.
    Meibohm B; Derendorf H
    Int J Clin Pharmacol Ther; 1997 Oct; 35(10):401-13. PubMed ID: 9352388
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multiple-pool cell lifespan model of hematologic effects of anticancer agents.
    Krzyzanski W; Jusko WJ
    J Pharmacokinet Pharmacodyn; 2002 Aug; 29(4):311-37. PubMed ID: 12518707
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetic modelling of serum and bronchial concentrations for clarithromycin and telithromycin, and site-specific pharmacodynamic simulation for their dosages.
    Ikawa K; Kikuchi E; Kikuchi J; Nishimura M; Derendorf H; Morikawa N
    J Clin Pharm Ther; 2014 Aug; 39(4):411-7. PubMed ID: 24661290
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Population pharmacokinetics and pharmacodynamics of BYL719, a phosphoinositide 3-kinase antagonist, in adult patients with advanced solid malignancies.
    De Buck SS; Jakab A; Boehm M; Bootle D; Juric D; Quadt C; Goggin TK
    Br J Clin Pharmacol; 2014 Sep; 78(3):543-55. PubMed ID: 24617631
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of four basic models of indirect pharmacodynamic responses.
    Sharma A; Jusko WJ
    J Pharmacokinet Biopharm; 1996 Dec; 24(6):611-35. PubMed ID: 9300353
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Population pharmacokinetics and pharmacodynamics of IONIS-GCGR
    Luu KT; Morgan ES; Bhanot S; Geary R; Smith A; Bethune C; Watts L; Henry S; Wang Y
    J Pharmacokinet Pharmacodyn; 2017 Jun; 44(3):179-191. PubMed ID: 28132162
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Optimal sampling times for a drug and its metabolite using SIMCYP(®) simulations as prior information.
    Dumont C; Mentré F; Gaynor C; Brendel K; Gesson C; Chenel M
    Clin Pharmacokinet; 2013 Jan; 52(1):43-57. PubMed ID: 23212609
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Simulation of the pharmacokinetics of bisoprolol in healthy adults and patients with impaired renal function using whole-body physiologically based pharmacokinetic modeling.
    Li GF; Wang K; Chen R; Zhao HR; Yang J; Zheng QS
    Acta Pharmacol Sin; 2012 Nov; 33(11):1359-71. PubMed ID: 23085739
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacodynamic model for chemoradiotherapy-induced thrombocytopenia in mice.
    Krzyzanski W; Perez-Ruixo JJ; Harrold J
    J Pharmacokinet Pharmacodyn; 2015 Dec; 42(6):709-20. PubMed ID: 26341875
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of pharmacodynamic recession slopes for direct and indirect response models.
    Krzyzanski W; Jusko WJ
    J Pharmacokinet Biopharm; 1998 Aug; 26(4):409-36. PubMed ID: 10214560
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An assessment of recombinant human erythropoietin effect on reticulocyte production rate and lifespan distribution in healthy subjects.
    Krzyzanski W; Perez-Ruixo JJ
    Pharm Res; 2007 Apr; 24(4):758-72. PubMed ID: 17318417
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ordinary differential equation approximation of gamma distributed delay model.
    Krzyzanski W
    J Pharmacokinet Pharmacodyn; 2019 Feb; 46(1):53-63. PubMed ID: 30617672
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanism-based pharmacokinetic/pharmacodynamic meta-analysis of trabectedin (ET-743, Yondelis) induced neutropenia.
    Hing J; Perez-Ruixo JJ; Stuyckens K; Soto-Matos A; Lopez-Lazaro L; Zannikos P
    Clin Pharmacol Ther; 2008 Jan; 83(1):130-43. PubMed ID: 17597713
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Population pharmacokinetics of oral levofloxacin in healthy volunteers and dosing optimization for multidrug-resistant tuberculosis therapy.
    Boonpeng A; Jaruratanasirikul S; Wattanavijitkul T; Nawakitrangsan M; Samaeng M
    Biopharm Drug Dispos; 2021 Jul; 42(7):329-337. PubMed ID: 34117648
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Meaningful interpretation of subdiffusive measurements in living cells (crowded environment) by fluorescence fluctuation microscopy.
    Baumann G; Place RF; Földes-Papp Z
    Curr Pharm Biotechnol; 2010 Aug; 11(5):527-43. PubMed ID: 20553227
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cellular pharmacokinetics: effects of cytoplasmic diffusion and binding on organ transit time distribution.
    Weiss M
    J Pharmacokinet Biopharm; 1999 Jun; 27(3):233-56. PubMed ID: 10728488
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Population In Vitro-In Vivo Correlation Model Linking Gastrointestinal Transit Time, pH, and Pharmacokinetics: Itraconazole as a Model Drug.
    Abuhelwa AY; Mudge S; Hayes D; Upton RN; Foster DJ
    Pharm Res; 2016 Jul; 33(7):1782-94. PubMed ID: 27119846
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A computer program for pharmacokinetics based on maximum likelihood estimation using the gamma distribution with a probability density function: comparison with the normal distribution.
    Tanikawa K; Matsumoto Y; Matsuzaki T; Shimizu M; Matsumoto M; Fukuoka M
    Biol Pharm Bull; 2000 Feb; 23(2):235-9. PubMed ID: 10706392
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.